{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:47:31Z","timestamp":1787032051959,"version":"build-2736575974"},"reference-count":49,"publisher":"Japan Atherosclerosis Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2025,2,1]]},"DOI":"10.5551\/jat.rv22030","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T17:12:57Z","timestamp":1731690777000},"page":"111-119","source":"Crossref","is-referenced-by-count":11,"title":["Atherosclerotic Diseases in Chronic Kidney Disease"],"prefix":"10.5551","volume":"32","author":[{"given":"Toshiaki","family":"Nakano","sequence":"first","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Levey AS, Coresh J. Chronic kidney disease. Lancet, 2012; 379: 165-180","DOI":"10.1016\/S0140-6736(11)60178-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Hill NR, Fatoba ST, Oke JL, Hirst JA, O\u2019Callaghan CA, Lasserson DS, Hobbs FD. Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis. PLoS One, 2016; 11: e0158765","DOI":"10.1371\/journal.pone.0158765"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Nakamura H, Mizuno K, Ohashi Y, Yoshida T, Hirao K, Uchida Y, Group MS. Pravastatin and cardiovascular risk in moderate chronic kidney disease. Atherosclerosis, 2009; 206: 512-517","DOI":"10.1016\/j.atherosclerosis.2009.03.031"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E, German D, Dialysis Study I. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med, 2005; 353: 238-248","DOI":"10.1056\/NEJMoa043545"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Fellstrom BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Gronhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Suleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wuthrich RP, Gottlow M, Johnsson E, Zannad F, Group AS. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med, 2009; 360: 1395-1407","DOI":"10.1056\/NEJMoa0810177"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Torii S, Sato Y, Otsuka F, Kolodgie FD, Jinnouchi H, Sakamoto A, Park J, Yahagi K, Sakakura K, Cornelissen A, Kawakami R, Mori M, Kawai K, Amoa F, Guo L, Kutyna M, Fernandez R, Romero ME, Fowler D, Finn AV, Virmani R. Eruptive Calcified Nodules as a Potential Mechanism of Acute Coronary Thrombosis and Sudden Death. J Am Coll Cardiol, 2021; 77: 1599-1611","DOI":"10.1016\/j.jacc.2021.02.016"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Caliskan Y, Demirturk M, Ozkok A, Yelken B, Sakaci T, Oflaz H, Unsal A, Yildiz A. Coronary artery calcification and coronary flow velocity in haemodialysis patients. Nephrol Dial Transplant, 2010; 25: 2685-2690","DOI":"10.1093\/ndt\/gfq113"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med, 2004; 351: 1296-1305","DOI":"10.1056\/NEJMoa041031"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Doi Y, Okubo K, Wakugawa Y, Hata J, Oishi Y, Shikata K, Yonemoto K, Hirakata H, Iida M. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int, 2005; 68: 228-236","DOI":"10.1111\/j.1523-1755.2005.00397.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Tonelli M, Karumanchi SA, Thadhani R. Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease. Circulation, 2016; 133: 518-536","DOI":"10.1161\/CIRCULATIONAHA.115.018713"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Chronic Kidney Disease Prognosis C, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet, 2010; 375: 2073-2081","DOI":"10.1016\/S0140-6736(10)60674-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kitamura H, Tanaka S, Hiyamuta H, Shimamoto S, Tsuruya K, Nakano T, Kitazono T. Cardiovascular Risk Factor Burden and Treatment Control in Patients with Chronic Kidney Disease: A Cross-Sectional Study. J Atheroscler Thromb, 2023; 30: 1210-1288","DOI":"10.5551\/jat.63891"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Nishimura K, Okamura T, Watanabe M, Nakai M, Takegami M, Higashiyama A, Kokubo Y, Okayama A, Miyamoto Y. Predicting coronary heart disease using risk factor categories for a Japanese urban population, and comparison with the framingham risk score: the suita study. J Atheroscler Thromb, 2014; 21: 784-798","DOI":"10.5551\/jat.19356"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Iseki K. Stroke feature and management in dialysis patients. Contrib Nephrol, 2013; 179: 100-109","DOI":"10.1159\/000346728"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Valdivielso JM, Rodriguez-Puyol D, Pascual J, Barrios C, Bermudez-Lopez M, Sanchez-Nino MD, Perez-Fernandez M, Ortiz A. Atherosclerosis in Chronic Kidney Disease: More, Less, or Just Different? Arterioscler Thromb Vasc Biol, 2019; 39: 1938-1966","DOI":"10.1161\/ATVBAHA.119.312705"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Nakano T, Katsuki S, Chen M, Decano JL, Halu A, Lee LH, Pestana DVS, Kum AST, Kuromoto RK, Golden WS, Boff MS, Guimaraes GC, Higashi H, Kauffman KJ, Maejima T, Suzuki T, Iwata H, Barabasi AL, Aster JC, Anderson DG, Sharma A, Singh SA, Aikawa E, Aikawa M. Uremic Toxin Indoxyl Sulfate Promotes Proinflammatory Macrophage Activation Via the Interplay of OATP2B1 and Dll4-Notch Signaling. Circulation, 2019; 139: 78-96","DOI":"10.1161\/CIRCULATIONAHA.118.034588"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Iseki K, Kinjo K, Kimura Y, Osawa A, Fukiyama K. Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int, 1993; 44: 1086-1090","DOI":"10.1038\/ki.1993.352"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Hanafusa K. 2022 Annual Dialysis Data Report, JSDT Renal Data Registry. J. Jpn. Soc. Dial. Ther., 2023; 56: 473-536","DOI":"10.4009\/jsdt.56.473"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, Iimuro S, Ohashi Y, Hishida A. Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol, 2010; 14: 558-570","DOI":"10.1007\/s10157-010-0328-6"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Tanaka S, Nakano T, Hiyamuta H, Tsuruya K, Kitazono T. Association between Multimorbidity and Kidney Function among Patients with Non-Dialysis-Dependent CKD: The Fukuoka Kidney Disease Registry Study. J Atheroscler Thromb, 2022; 29: 1249-1264","DOI":"10.5551\/jat.62900"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Iwasaki M, Joki N, Tanaka Y, Hayashi T, Kubo S, Asakawa T, Matsukane A, Takahashi Y, Hirahata K, Imamura Y, Hase H. Declining prevalence of coronary artery disease in incident dialysis patients over the past two decades. J Atheroscler Thromb, 2014; 21: 593-604","DOI":"10.5551\/jat.21337"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Nakano T, Ninomiya T, Sumiyoshi S, Fujii H, Doi Y, Hirakata H, Tsuruya K, Iida M, Kiyohara Y, Sueishi K. Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study. Am J Kidney Dis, 2010; 55: 21-30","DOI":"10.1053\/j.ajkd.2009.06.034"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int, 2007; 71: 438-441","DOI":"10.1038\/sj.ki.5002059"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Micheletti RG, Fishbein GA, Currier JS, Fishbein MC. Monckeberg sclerosis revisited: a clarification of the histologic definition of Monckeberg sclerosis. Arch Pathol Lab Med, 2008; 132: 43-47","DOI":"10.5858\/2008-132-43-MSRACO"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant, 2003; 18: 1731-1740","DOI":"10.1093\/ndt\/gfg414"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Nakamura S, Ishibashi-Ueda H, Niizuma S, Yoshihara F, Horio T, Kawano Y. Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol, 2009; 4: 1892-1900","DOI":"10.2215\/CJN.04320709"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, Gill JS, Hlatky MA, Jardine AG, Landmesser U, Newby LK, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, Marwick TH, Conference P. Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review. J Am Coll Cardiol, 2019; 74: 1823-1838","DOI":"10.1016\/j.jacc.2019.08.1017"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res, 2014; 114: 1852-1866","DOI":"10.1161\/CIRCRESAHA.114.302721"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Jinnouchi H, Sato Y, Sakamoto A, Cornelissen A, Mori M, Kawakami R, Gadhoke NV, Kolodgie FD, Virmani R, Finn AV. Calcium deposition within coronary atherosclerotic lesion: Implications for plaque stability. Atherosclerosis, 2020; 306: 85-95","DOI":"10.1016\/j.atherosclerosis.2020.05.017"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Sakaguchi M, Hasegawa T, Ehara S, Matsumoto K, Mizutani K, Iguchi T, Ishii H, Nakagawa M, Shimada K, Yoshiyama M. New insights into spotty calcification and plaque rupture in acute coronary syndrome: an optical coherence tomography study. Heart Vessels, 2016; 31: 1915-1922","DOI":"10.1007\/s00380-016-0820-3"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Nakano T, Kitamura H, Hata J, Maki K, Oda Y, Kitazono T, Ninomiya T. Association between Vascular Calcification and Intraplaque Hemorrhage in Coronary Atherosclerosis from Autopsy: The Hisayama Study. J Atheroscler Thromb, 2024; 31: 1225-1237","DOI":"10.5551\/jat.64394"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Stewart GA, Gansevoort RT, Mark PB, Rooney E, McDonagh TA, Dargie HJ, Stuart R, Rodger C, Jardine AG. Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int, 2005; 67: 217-226","DOI":"10.1111\/j.1523-1755.2005.00072.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Moran A, Katz R, Jenny NS, Astor B, Bluemke DA, Lima JA, Siscovick D, Bertoni AG, Shlipak MG. Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C: the multi-ethnic study of atherosclerosis (MESA). Am J Kidney Dis, 2008; 52: 839-848","DOI":"10.1053\/j.ajkd.2008.06.012"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Izumaru K, Hata J, Nakano T, Nakashima Y, Nagata M, Fukuhara M, Oda Y, Kitazono T, Ninomiya T. Reduced Estimated GFR and Cardiac Remodeling: A Population-Based Autopsy Study. Am J Kidney Dis, 2019; 74: 373-381","DOI":"10.1053\/j.ajkd.2019.02.013"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Campese VM. Left ventricular function and chronic kidney disease: how soon does it start? Nephrol Dial Transplant, 2014; 29: 1989-1991","DOI":"10.1093\/ndt\/gfu223"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Achinger SG, Ayus JC. Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor? J Am Soc Nephrol, 2006; 17: S255-261","DOI":"10.1681\/ASN.2006080923"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Pepine CJ. ANOCA\/INOCA\/MINOCA: Open artery ischemia. Am Heart J Plus, 2023; 26","DOI":"10.1016\/j.ahjo.2023.100260"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Eggers KM, Hjort M, Baron T, Jernberg T, Nordenskjold AM, Tornvall P, Lindahl B. Morbidity and cause-specific mortality in first-time myocardial infarction with nonobstructive coronary arteries. J Intern Med, 2019; 285: 419-428","DOI":"10.1111\/joim.12857"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Jain V, Gupta K, Bhatia K, Rajapreyar I, Singh A, Zhou W, Klein A, Nanda NC, Prabhu SD, Bajaj NS. Coronary flow abnormalities in chronic kidney disease: A systematic review and meta-analysis. Echocardiography, 2022; 39: 1382-1390","DOI":"10.1111\/echo.15445"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Nishimura M, Tsukamoto K, Hasebe N, Tamaki N, Kikuchi K, Ono T. Prediction of cardiac death in hemodialysis patients by myocardial fatty acid imaging. J Am Coll Cardiol, 2008; 51: 139-145","DOI":"10.1016\/j.jacc.2007.08.057"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Masson P, Webster AC, Hong M, Turner R, Lindley RI, Craig JC. Chronic kidney disease and the risk of stroke: a systematic review and meta-analysis. Nephrol Dial Transplant, 2015; 30: 1162-1169","DOI":"10.1093\/ndt\/gfv009"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Yamada S, Tsuruya K, Taniguchi M, Tokumoto M, Fujisaki K, Hirakata H, Fujimi S, Kitazono T. Association Between Serum Phosphate Levels and Stroke Risk in Patients Undergoing Hemodialysis: The Q-Cohort Study. Stroke, 2016; 47: 2189-2196","DOI":"10.1161\/STROKEAHA.116.013195"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Uchida Y, Nakano T, Kitamura H, Taniguchi M, Tsuruya K, Kitazono T. Association between hyporesponsiveness to erythropoiesis-stimulating agents and risk of brain hemorrhage in patients undergoing hemodialysis: the Q-Cohort Study. Clin Exp Nephrol, 2023; 27: 79-88","DOI":"10.1007\/s10157-022-02278-x"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Robinson BM, Bieber B, Pisoni RL, Port FK. Dialysis Outcomes and Practice Patterns Study (DOPPS): its strengths, limitations, and role in informing practices and policies. Clin J Am Soc Nephrol, 2012; 7: 1897-1905","DOI":"10.2215\/CJN.04940512"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Hara M, Tanaka S, Taniguchi M, Fujisaki K, Torisu K, Masutani K, Hirakata H, Nakano T, Tsuruya K, Kitazono T. Prognostic value of pre-dialysis blood pressure and risk threshold on clinical outcomes in hemodialysis patients: The Q-Cohort Study. Medicine (Baltimore), 2018; 97: e13485","DOI":"10.1097\/MD.0000000000013485"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Nakano T, Hiyamuta H, Yotsueda R, Tanaka S, Taniguchi M, Tsuruya K, Kitazono T. Higher Cholesterol Level Predicts Cardiovascular Event and Inversely Associates With Mortality in Hemodialysis Patients: 10-Year Outcomes of the Q-Cohort Study. Ther Apher Dial, 2020; 24: 431-438","DOI":"10.1111\/1744-9987.13455"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Shimamoto S, Yamada S, Hiyamuta H, Arase H, Taniguchi M, Tokumoto M, Nakano T, Tsuruya K, Kitazono T. Association of serum phosphate concentration with the incidence of intervention for peripheral artery disease in patients undergoing hemodialysis: 10-year outcomes of the Q-Cohort Study. Atherosclerosis, 2020; 304: 22-29","DOI":"10.1016\/j.atherosclerosis.2020.04.022"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Kutikhin AG, Feenstra L, Kostyunin AE, Yuzhalin AE, Hillebrands JL, Krenning G. Calciprotein Particles: Balancing Mineral Homeostasis and Vascular Pathology. Arterioscler Thromb Vasc Biol, 2021; 41: 1607-1624","DOI":"10.1161\/ATVBAHA.120.315697"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Massy ZA, Merkling T, Wagner S, Girerd N, Essig M, Wanner C, Fellstrom BC, Rossignol P, Zannad F. Association of Serum Phosphate with Efficacy of Statin Therapy in Hemodialysis Patients. Clin J Am Soc Nephrol, 2022; 17: 546-554","DOI":"10.2215\/CJN.12620921"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/2\/32_RV22030\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T23:38:37Z","timestamp":1738366717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/2\/32_RV22030\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.rv22030","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,1]]},"article-number":"RV22030"}}